acellular pertussis vaccine/diphtheria toxoid/haemophilus b vaccine/poliovirus vaccine inactivated/tetanus toxoid; DTaP-IPV/Hib (Pentacel)
Jump to navigation
Jump to search
Introduction
combined diphtheria, tetanus toxoids & acellular pertussis, inactivated poliovirus, & Haemophilus influenzae type B conjugate vaccine
Indications
- 4-dose series at ages 2, 4, 6, & 15 to 18 months
More general terms
References
- ↑ Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, & Haemophilus b Conjugate Vaccine and Guidance for Use in Infants and Children MMWR October 3, 2008 / 57(39);1079-1080 http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5739a5.htm
- ↑ Food and Drug Administration. Product approval information: package insert. Pentacel (diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and Haemophilus b conjugate [tetanus toxoid conjugate] vaccine. http://www.fda.gov/cber/products/pentacel.htm